Amoy Diagnostics Co., Ltd. (SHE:300685)
23.57
+0.21 (0.90%)
Sep 18, 2025, 11:44 AM CST
Amoy Diagnostics Market Cap
Amoy Diagnostics has a market cap or net worth of 9.04 billion as of September 17, 2025. Its market cap has increased by 28.66% in one year.
Market Cap
9.04B
Enterprise Value
7.89B
Revenue
1.15B
Ranking
n/a
PE Ratio
30.78
Stock Price
23.57
Market Cap Chart
Since August 2, 2017, Amoy Diagnostics's market cap has increased from 1.60B to 9.04B, an increase of 465.95%. That is a compound annual growth rate of 23.76%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 17, 2025 | 9.04B | 0.66% |
Dec 31, 2024 | 8.98B | 3.50% |
Dec 29, 2023 | 8.67B | -17.63% |
Dec 30, 2022 | 10.53B | -37.10% |
Dec 31, 2021 | 16.74B | -3.54% |
Dec 31, 2020 | 17.36B | 76.45% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Aug 2, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 460.12B |
WuXi AppTec | 307.21B |
Shenzhen Mindray Bio-Medical Electronics | 289.77B |
Sichuan Biokin Pharmaceutical | 141.91B |
Shanghai United Imaging Healthcare | 124.64B |
Zhangzhou Pientzehuang Pharmaceutical., | 121.88B |
Aier Eye Hospital Group | 119.82B |
Yunnan Baiyao Group Co.,Ltd | 105.25B |